Inventiva (IVA) FCF Margin (2020 - 2022)

Inventiva (IVA) recorded quarterly FCF Margin of 682.96% in Q4 2022, up 96.27% quarter-over-quarter from 18298.46% in Q2 2021.

Inventiva (IVA) FCF Margin (2020 - 2022) Analysis & Trends

Inventiva's FCF Margin history runs 3 years deep, the most recent figure standing at 682.96% for Q4 2022.

  • In Q4 2022, FCF Margin changed N/A year-over-year to 682.96%; the TTM figure through Dec 2022 stood at 1842.88% (changed N/A YoY), while the FY2025 annual figure was 2345.1%, down 140728.0% from the prior year.
  • FCF Margin was 682.96% for Q4 2022 at Inventiva, up from 18298.46% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 682.96% in Q4 2022 to a low of 18298.46% in Q2 2021.
  • Historically, FCF Margin has averaged 7681.97% across 3 years, with a median of 4854.05% in 2020.
  • Biggest YoY gain for FCF Margin was 634452 bps in 2021; the steepest drop was 1344441 bps in 2021.
  • A 3-year view of FCF Margin shows it stood at 4854.05% in 2020, then slumped by 277 bps to 18298.46% in 2021, then surged by 96 bps to 682.96% in 2022.
  • The last three FCF Margin figures came in at 682.96% (Q4 2022), 18298.46% (Q2 2021), and 10459.46% (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 43.35%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Inventiva 8.93 Mn -259.80 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -682.96%
Jun 30, 2021 -18,298.46%
Mar 31, 2021 -10,459.46%
Jun 30, 2020 -4,854.05%
Mar 31, 2020 -4,114.94%